<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39376867</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Meningococcal Pneumonia in a Patient With Pulmonary Amyloidosis and a Recent COVID-19 Infection.</ArticleTitle><Pagination><StartPage>e68840</StartPage><MedlinePgn>e68840</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68840</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68840</ELocationID><Abstract><AbstractText>A 64-year-old man visited our outpatient clinic with chief complaints of high fever and throat pain. His medical history was significant for pulmonary amyloidosis that was observed at our outpatient clinic, and his recent recovery from COVID-19. Findings from imaging studies included thickening of the bronchial walls, infiltrates of the left upper lobe, and pre-existing pulmonary nodules from amyloidosis. A peripheral blood examination revealed leukocytosis and elevated C-reactive protein levels. His signs and symptoms suggested bronchopneumonia and antimicrobial treatment was initiated. Sputum microscopic examination revealed gram-negative cocci and culture growth revealed to be <i>Neisseria meningitidis</i>, with follow-up bacterial specimens after treatment demonstrating diminished microbes. Despite a medical history of amyloidosis and COVID-19, the patient's clinical course resulted in favorable outcomes. The <i>N. meningitidis</i> infection is a rare condition in generally healthy individuals, and certain conditions may be related to the contraction of the pathogen, otherwise seen primarily in immunocompromised hosts. In our case, the medical history of amyloidosis and recent COVID-19 infection may have contributed to the development of meningococcal bronchopneumonia.</AbstractText><CopyrightInformation>Copyright © 2024, Konishi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Konishi</LastName><ForeName>Kazuhisa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Toshiyuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Kohei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Taisuke</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takumi</LastName><ForeName>Chieko</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid associated pneumonia</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">neisseria meningitidis</Keyword><Keyword MajorTopicYN="N">pulmonary amyloidosis</Keyword><Keyword MajorTopicYN="N">respiratory disease</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39376867</ArticleId><ArticleId IdType="pmc">PMC11456771</ArticleId><ArticleId IdType="doi">10.7759/cureus.68840</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Invasive meningococcal disease in the 21st century—an update for the clinician. Dwilow R, Fanella S. Curr Neurol Neurosci Rep. 2015;15:2.</Citation><ArticleIdList><ArticleId IdType="pubmed">25637287</ArticleId></ArticleIdList></Reference><Reference><Citation>Meningococcal disease in Los Angeles County, California, and among men in the county jails. Tappero JW, Reporter R, Wenger JD, et al. N Engl J Med. 1996;335:833–840.</Citation><ArticleIdList><ArticleId IdType="pubmed">8778600</ArticleId></ArticleIdList></Reference><Reference><Citation>Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. Scarborough M, Gordon SB, Whitty CJ, et al. N Engl J Med. 2007;357:2441–2450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068549</ArticleId><ArticleId IdType="pubmed">18077809</ArticleId></ArticleIdList></Reference><Reference><Citation>Early detection of multiorgan light-chain amyloidosis by whole-body (18)f-florbetapir PET/CT. Ehman EC, El-Sady MS, Kijewski MF, et al. J Nucl Med. 2019;60:1234–1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735282</ArticleId><ArticleId IdType="pubmed">30954943</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Noursadeghi M, Bickerstaff MC, Gallimore JR, Herbert J, Cohen J, Pepys MB. Proc Natl Acad Sci U S A. 2000;97:14584–14589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18962</ArticleId><ArticleId IdType="pubmed">11121061</ArticleId></ArticleIdList></Reference><Reference><Citation>Co-infection in COVID-19 pneumonia: discussion continues. Strelkova D, Rachina S, Klimenko A, et al. Infect Chemother. 2022;54:792–796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9840957</ArticleId><ArticleId IdType="pubmed">36596687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacterial community- and hospital-acquired pneumonia in patients with critical COVID-19-a prospective monocentric cohort study. Doubravská L, Sedláková MH, Fišerová K, Klementová O, Turek R, Langová K, Kolář M. Antibiotics (Basel) 2024;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10886267</ArticleId><ArticleId IdType="pubmed">38391578</ArticleId></ArticleIdList></Reference><Reference><Citation>Visualizing omicron: COVID-19 deaths vs. cases over time. Arnaout R, Arnaout R. PLoS One. 2022;17:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017933</ArticleId><ArticleId IdType="pubmed">35439253</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory microbiome and epithelial interactions shape immunity in the lungs. Invernizzi R, Lloyd CM, Molyneaux PL. Immunology. 2020;160:171–182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218407</ArticleId><ArticleId IdType="pubmed">32196653</ArticleId></ArticleIdList></Reference><Reference><Citation>The lung in dysregulated States of humoral immunity. Uzunhan Y, Jeny F, Kambouchner M, et al. Respiration. 2017;94:389–404.</Citation><ArticleIdList><ArticleId IdType="pubmed">28910817</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>